Annual Operating Expenses
$35.74 M
+$12.01 M+50.61%
December 31, 2023
Summary
- As of February 8, 2025, ELTX annual total operating expenses is $35.74 million, with the most recent change of +$12.01 million (+50.61%) on December 31, 2023.
- During the last 3 years, ELTX annual operating expenses has risen by +$20.02 million (+127.37%).
- ELTX annual operating expenses is now at all-time high.
Performance
ELTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$10.34 M
-$580.00 K-5.31%
September 30, 2024
Summary
- As of February 8, 2025, ELTX quarterly total operating expenses is $10.34 million, with the most recent change of -$580.00 thousand (-5.31%) on September 30, 2024.
- Over the past year, ELTX quarterly operating expenses has dropped by -$427.00 thousand (-3.96%).
- ELTX quarterly operating expenses is now -5.31% below its all-time high of $10.92 million, reached on June 30, 2024.
Performance
ELTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ELTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +50.6% | -4.0% |
| 3 y3 years | +127.4% | +32.5% |
| 5 y5 years | +189.6% | +32.5% |
ELTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +50.6% | -5.3% | +79.3% |
| 5 y | 5-year | at high | +189.6% | -5.3% | +243.6% |
| alltime | all time | at high | +189.6% | -5.3% | +243.6% |
Elicio Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.34 M(-5.3%) |
| Jun 2024 | - | $10.92 M(+6.7%) |
| Mar 2024 | - | $10.24 M(+9.0%) |
| Dec 2023 | $35.74 M(+50.6%) | $9.39 M(-12.8%) |
| Sep 2023 | - | $10.77 M(+38.5%) |
| Jun 2023 | - | $7.78 M(-0.4%) |
| Mar 2023 | - | $7.80 M(+30.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $23.73 M(-6.8%) | $5.96 M(+3.3%) |
| Sep 2022 | - | $5.77 M(-7.4%) |
| Jun 2022 | - | $6.23 M(+0.6%) |
| Dec 2021 | $25.47 M(+62.0%) | - |
| Mar 2021 | - | $6.19 M(+105.7%) |
| Dec 2020 | $15.72 M(+27.4%) | - |
| Mar 2020 | - | $3.01 M |
| Dec 2019 | $12.34 M | - |
FAQ
- What is Elicio Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Elicio Therapeutics?
- What is Elicio Therapeutics annual operating expenses year-on-year change?
- What is Elicio Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Elicio Therapeutics?
- What is Elicio Therapeutics quarterly operating expenses year-on-year change?
What is Elicio Therapeutics annual total operating expenses?
The current annual operating expenses of ELTX is $35.74 M
What is the all time high annual operating expenses for Elicio Therapeutics?
Elicio Therapeutics all-time high annual total operating expenses is $35.74 M
What is Elicio Therapeutics annual operating expenses year-on-year change?
Over the past year, ELTX annual total operating expenses has changed by +$12.01 M (+50.61%)
What is Elicio Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ELTX is $10.34 M
What is the all time high quarterly operating expenses for Elicio Therapeutics?
Elicio Therapeutics all-time high quarterly total operating expenses is $10.92 M
What is Elicio Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ELTX quarterly total operating expenses has changed by -$427.00 K (-3.96%)